Jason B. White
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Cancer Genomics and Diagnostics, Cancer Treatment and Pharmacology, MRI in cancer diagnosis, Cancer Cells and Metastasis
Most-Cited Works
- → Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer(2021)74 cited
- → MRI-Based Digital Models Forecast Patient-Specific Treatment Responses to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer(2022)69 cited
- → Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI(2023)41 cited
- → Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer(2022)40 cited
- → A model combining pretreatment MRI radiomic features and tumor-infiltrating lymphocytes to predict response to neoadjuvant systemic therapy in triple-negative breast cancer(2022)36 cited
- → A phase I/II trial of brachytherapy alone following lumpectomy for select breast cancer: toxicity analysis of radiation therapy oncology group 95-17(2002)33 cited
- → Pharmacokinetic (PK) analyses in CSF and plasma from TBCRC049, an ongoing trial to assess the safety and efficacy of the combination of tucatinib, trastuzumab and capecitabine for the treatment of leptomeningeal metastasis (LM) in HER2 positive breast cancer.(2021)29 cited
- → Functional Tumor Volume by Fast DynamicContrast‐Enhanced MRIfor Predicting Neoadjuvant Systemic Therapy Response inTriple‐NegativeBreast Cancer(2021)28 cited
- → A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast Cancer(2023)28 cited
- Expression of secreted frizzled-related protein 4 (SFRP4) in primary serous ovarian tumours.(2009)